The Adjusted Logo of Godoy Medical Marketing (GMM)

Protocol Cost = Fixed Signal

Medixlinx operates on a deterministic flat fee: $2,300.00/month.
Billed monthly. No tiers. No media spend. No performance variability.

One Fee. No Variants. No Multipliers.

Flat Structural Fee

$2,300.00/month. Not tied to leads, patients, clicks, or budget caps. You’re not buying campaigns—you’re accessing deterministic routing infrastructure that directs qualified intake into your system. There are no incentives, bundles, or thresholds. This fee does not change if you add locations, expand specialties, or grow throughput. It reflects operational structure, not performance speculation.

Monthly Protocol Window

Medixlinx runs on a rolling monthly protocol window: a flat fee of $2,300.00/month. No lock-in. No early termination fees. No midstream adjustments. Routing stays live regardless of platform updates, patient volume, or revenue cycles. We don’t monitor your performance—we map your intake structure. Thus, this isn’t a subscription. It’s alignment with a deterministic routing protocol, on this system's terms.

System Inclusion, Not Feature Access

There’s nothing to configure, toggle, or unlock. Once your system is aligned, routing activates. You’re not getting “features”—you’re getting structured patient flow into your existing intake channels. There are no training portals, admin roles, or usage restrictions. This is infrastructure-level access. If your EMR, call center, or scheduling stack is compatible, routing begins. Instantly.

Zero Add-Ons or Platform Fees

GMM will not bill you for setup, integration, “premium support,” or add-on modules. There is no media budget. No optimization hours. No campaign spend. You’re not paying for effort—you’re paying for signal routing. Medixlinx doesn’t monetize confusion. Everything needed to route into your ops stack is included. Nothing else is offered, because nothing else is needed.

Realignment, Not Renewal

No Auto-Renewal

Medixlinx runs on a rolling monthly protocol window. There are no reminders, retention efforts, or renewal cycles. Continuation is not assumed; it’s conditional on alignment. If you give notice or your intake structure drifts out of protocol, billing stops, and routing pauses. Nothing gets “grandfathered in.” If your network still fits, a new window is opened through realignment, in these system terms.

System Re-Evaluation

Medical systems evolve. So does intake structure. Whenever your EMR, scheduling, triage, staffing, or routing endpoints change, your system must be re-aligned to the Medixlinx protocol. Thus, this is not a check-in; it’s a requalification. If logic holds, routing stays active. If not, routing pauses and billing stops. There is no partial fit. Medixlinx runs only under total alignment.

Fresh Protocol Window

If your system passes realignment, routing continues under a fresh protocol window—at that fixed cost. There are no escalator clauses. No grandfathering. No legacy privileges. That’s why this isn’t a renewal; it’s re-entry on clean terms. Your system is treated as new so that the infrastructure can reset, and the logic stays deterministic.

If Misaligned, It Ends

If your system diverges—through software changes, staffing shifts, or intake drift—routing stops. First with a single notice. Then, if not promptly realigned, it ends entirely. GMM does not adapt the protocol to partial fit. Medixlinx remains passive. No downgrade. No appeal. No transition. Intake halts system-wide. This is not a penalty. It is simply the result of misalignment.

Why Flat? Because the Protocol Doesn’t Flex

Routing Is System-Bound, Not Volume-Based

Patient volume doesn’t change the logic. Whether you intake 500 or 5,000 patients a month, routing occurs the same way: through system-aligned entry points. Medixlinx is not a media engine. It doesn’t scale effort with activity. One protocol, one logic path. Your cost reflects architectural participation, not operational throughput. Volume may vary. The protocol never does.

No Performance-Based Modifiers

There are no incentives for “conversion rates,” no charges for “lead quality,” and no bonuses for “growth milestones.” Medixlinx doesn’t monitor your results. It routes by structure, not outcome. You’re not billed more if routing succeeds—or less if it doesn’t. This is infrastructure, not speculation. Protocol fit determines activation. Not revenue. Not ROI. Not clinical metrics.

Locations Don’t Multiply Cost

Whether you operate two clinics or 200, your cost stays flat. The protocol reads system architecture—not facility count. If your intake, scheduling, and EMR routing stack is unified, Medixlinx treats it as a single operational logic map. You’re not charged per ZIP code, provider, or point of care. Complexity doesn’t inflate cost. Fit activates routing.

Invariant by Design

There is no “pricing conversation.” No variable clause. No platform-level override. The cost is fixed because the logic is fixed. Medixlinx does not accommodate strategic shifts, campaign pivots, or budget fluctuations. Once activated, the protocol functions independently of context. It either routes into your system—or it doesn’t. The fee reflects that certainty. Not marketing elasticity.

Legacy Marketing Models vs Protocol Logic

Variable Pricing vs Fixed Protocol Cost

Legacy firms price by campaign complexity, media spend, and negotiated scope. You’re rewarded with ambiguity and penalized for scale. Medixlinx doesn’t bid, flex, or scale pricing. One fee powers deterministic routing across your system—regardless of location count, patient flow, or seasonality. You’re not buying labor. You’re synchronizing logic. Cost is flat because routing is fixed.

Performance Metrics vs Structural Fit

Agencies measure “success” by KPIs: impressions, leads, click-throughs. Those metrics are artifacts of speculation. Medixlinx ignores performance entirely. If your intake architecture aligns with the protocol, patients are routed. If not, nothing moves. You’re not optimizing results—you’re structurally qualifying for inclusion. Fit governs function. Not analytics. Not dashboards. Not vanity data.

Feature Packages vs System Admission

Most platforms bundle features into bronze/silver/gold tiers. You pay for access, then manage complexity. Medixlinx has no tiers—just inclusion or exclusion. There’s nothing to unlock, activate, or scale. If your system is mapped, routing runs. There’s no UI. No CRM integrations. No learning curve. You’re not upgrading—you’re participating. The only feature is structural compatibility.

Retention Tactics vs Exit by Misalignment

Marketing vendors extend contracts, offer discounts, and reduce fees to retain you. Medixlinx does none of that. Continuation is validated, not negotiated. When your intake structure changes, we reevaluate fit. If alignment holds, routing continues. If it doesn’t, routing ends—without penalty or persuasion. Retention is irrelevant. Participation is re-earned through logic, not loyalty. You’re never locked in. But you’re never assumed in, either.

What You Pay For

Intake Topology Mapping

Your system’s intake stack—EMR logic, scheduling flows, call centers, webforms—is mapped for routing viability. This includes infrastructure parsing, entry-point testing, and logic stack synthesis. You’re not paying for setup. You’re paying to determine whether your system is routable at all. If it isn’t, nothing moves. If it is, routing activates. Only structure matters. Not preference.

Deterministic Routing Schema

GMM constructs a non-branching logic map that aligns with your operational intake conditions. This schema governs routing priority, filtering criteria, overflow logic, and system frequency. No toggles. No test variants. No experimentation. You’re not paying for optimization—you’re paying for structural precision. Once schema alignment is verified, routing behaves identically every time. Deterministic means deterministic.

System Interface Coordination

GMM maintains live coordination with your intake endpoints across scheduling APIs, messaging logic, direct staff escalation, and call routing. This ensures flow continuity without relying on integrations, dashboards, or manual triggers. You are not paying for a platform. You are paying for clean interface logic between AGI agents and your internal intake architecture. Quiet. Structural. Precise.

Protocol Continuity + Maintenance

Routing integrity is monitored continuously for degradation caused by system drift—staffing changes, policy edits, or routing logic divergence. If your intake structure remains aligned, routing continues. If integrity breaks, GMM pauses routing, and billing stops. You’re not paying for “support” or tuning; you’re paying for a fixed logic system that functions only when alignment is intact.

Protocol Legal Logic (Not a Contract)

There is no agreement. Only structural participation.

📄 Medixlinx Protocol Legal Logic

  1. GMM operates Medixlinx as a deterministic patient routing protocol—not a service or platform.
  2. Participation begins only upon full system alignment. No partial access. No trial mode.
  3. The monthly fee is fixed at $2,300.00. It is non-negotiable and not linked to usage, performance, or patient volume.
  4. There are no additional charges: no media markup, no add-ons, no platform fees.
  5. Routing halts if your system diverges from protocol logic. No downgrade path, no appeals, no refunds.
  6. Participation ends automatically upon notice or protocol misalignment. Re-entry requires realignment.

☑ This logic box is not a contract. It affirms deterministic inclusion criteria only.

Ready to Route?

There is no demo, pitch, or sales call. If your intake structure—scheduling logic, EMR stack, flow integrity—matches protocol criteria, routing begins. If it doesn’t, you’ll know exactly why.

There is nothing to trial. Nothing to negotiate. Medixlinx doesn’t perform. It either activates or it doesn’t.
Submit your system. That’s the first—and only—step.
The Logo of Godoy Medical Marketing (GMM)
© 2026 Godoy Medical Marketing. All Rights Reserved.
Medixlinx™ is a deterministic patient routing protocol operated by Godoy Medical Marketing.